Statin Use and the Risk of Age Related Macular Degeneration in a Large Health Organization in Israel

Author： Shalev Varda   Sror Miri   Goldshtein Inbal   Kokia Ehud   Chodick Gabriel  

Publisher： Informa Healthcare

ISSN： 0928-6586

Source： Ophthalmic Epidemiology, Vol.18, Iss.2, 2011-04, pp. : 83-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins Do Not Decrease the Risk for Wet Age-Related Macular Degeneration

By Kaiserman Nadia   Vinker Shlomo   Kaiserman Igor  

Current Eye Research, Vol. 34, Iss. 4, 2009-04 ,pp. : 304-310

Informa Healthcare

Access to resources Recommend Favorite

Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response

By  

Ophthalmologica, Vol. 236, Iss. 2, 2016-07 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Risk Prediction Model for Progression of Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 57, Iss. 1, 2016-10 ,pp. : 32-36

Karger

Access to resources Recommend Favorite

Computer Use among Patients with Age-Related Macular Degeneration

By Brody Barbara L.   Field Linda C.   Roch-Levecq Anne-Catherine   Depp Colin   Edland Steven D.   Minasyan Lilit   Brown Stuart I.  

Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. : 190-195

Informa Healthcare

Access to resources Recommend Favorite

Compassionate Use of Intravitreal Pegaptanib in Patients with Age-Related Macular Degeneration

By Ricci Federico   Missiroli Filippo   Cedrone Claudio   Grossi Massimo   Regine Federico  

Seminars in Ophthalmology, Vol. 25, Iss. 1-2, 2010-03 ,pp. : 16-20

Informa Healthcare

Access to resources Recommend Favorite